Format

Send to

Choose Destination
Abdom Radiol (NY). 2019 May;44(5):1686-1702. doi: 10.1007/s00261-018-01888-y.

Mucinous appendiceal neoplasms: classification, imaging, and HIPEC.

Author information

1
Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
2
Department of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
3
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
4
Department of Radiology, Mayo Clinic, Scottsdale, AZ, USA.
5
Department of General Surgery, Mayo Clinic, Scottsdale, AZ, USA.
6
Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Sheedy.Shannon@mayo.edu.

Abstract

Recent advances, specifically cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC), offer advantages compared to the traditional therapeutic approach of systemic chemotherapy in the treatment of peritoneal carcinomatosis from mucinous appendiceal neoplasms (MAN). This review provides an up-to-date, comprehensive summary of the histologic classification of MAN, reviews common imaging findings of mucoceles and pseudomyxoma peritonei, and describes the radiologist's role in the multidisciplinary care team in quantifying disease and in helping select patients for definitive surgery.

KEYWORDS:

Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy, HIPEC; Mucinous appendiceal neoplasm, MAN; Pseudomyxoma peritonei, PMP

PMID:
30610247
DOI:
10.1007/s00261-018-01888-y

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center